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ABSTRACT
Mitochondrion is known as the energy factory of the cell,
which is also a unique mammalian organelle and con-
sidered to be evolved from aerobic prokaryotes more
than a billion years ago. Mitochondrial DNA, similar to
that of its bacterial ancestor’s, consists of a circular loop
and contains signiﬁcant number of unmethylated DNA
as CpG islands. The innate immune system plays an
important role in the mammalian immune response.
Recent research has demonstrated that mitochondrial
DNA (mtDNA) activates several innate immune path-
ways involving TLR9, NLRP3 and STING signaling,
which contributes to the signaling platforms and results
in effector responses. In addition to facilitating antibac-
terial immunity and regulating antiviral signaling,
mounting evidence suggests that mtDNA contributes to
inﬂammatory diseases following cellular damage and
stress. Therefore, in addition to its well-appreciated
roles in cellular metabolism and energy production,
mtDNA appears to function as a key member in the
innate immune system. Here, we highlight the emerging
roles of mtDNA in innate immunity.
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INTRODUCTION
Microorganisms that cause disease in humans and animals
enter the body at different sites and produce disease
symptoms via different mechanisms. Innate immune
response, or innate immunity, could immediately act as the
ﬁrst line of defense against various pathogens and do not
involve the activation of antigen-speciﬁc lymphocytes. Innate
immunity is sufﬁcient to prevent the body from being
routinely overwhelmed by a wide range of microorganisms
that live on or in it (Kenneth, 2011).
Mitochondria are known as the energy factories of the
cell, which are also unique mammalian organelles and
considered to be evolved from aerobic prokaryotes more
than a billion years ago (Dyall et al., 2004). Mitochondrion
contains its own genetic material, mitochondrial DNA
(mtDNA). Human mtDNA exists as a double-stranded cir-
cular loop of 16,569 bp, encoding rRNAs and tRNAs as well
as 13 respiratory chain subunits (Larsson, 2010). Mito-
chondrial DNA, similar to that of its bacterial ancestor’s,
consists of a circular loop and contains signiﬁcant number of
unmethylated DNA as CpG islands (Yu and Bennett, 2014).
Recent research has demonstrated that mtDNA participates
in different kinds of innate immune modulation, by activating
molecular pathways or causing pathologies. Mounting evi-
dence suggests that mtDNA does not only facilitate
antibacterial immunity and regulate antiviral signaling, but
also contribute to inﬂammatory diseases following cellular
damage and stress. Here, we review and discuss the
involvement of mtDNA in innate immune signaling pathways
and the mechanisms how it contributes to the pathologies of
inﬂammation and related disease.
MITOCHONDRIAL DNA AND PATHWAY ACTIVATION
Mitochondrial DNA contains signiﬁcant number of unmethy-
lated CpG DNA repeats that are similar to bacterial genomes.
To date, several receptors and molecular pathways are
reported during mtDNA function in innate immune response.
The role of mtDNA as damage-associated molecular patterns
(DAMPs) in inﬂammation initiation through Toll-like receptor 9
(TLR9) was characterized and its key role in provoking the
NLRP3 inﬂammasome was also reported. Mitochondrial DNA
also triggers stimulator of interferon genes (STING) signaling.
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A view of the mtDNA-TLR9 relationship
In recent years, the role of mtDNA as DAMPs is recognized,
which are endogenous molecules released by cells under-
going abnormal cell death (e.g. during pathological insult)
and capable of activating innate immune response. DAMPs
could be recognized by same receptors in pathogen-asso-
ciated molecular patterns (PAMPs) recognition, such as the
pattern recognition receptors (PRRs). Recently, the role of
mtDNA as DAMPs in inﬂammation initiation has gained
much attention.
Bacterial DNA is recognized by TLR9, a member of the
highly conserved PRRs known as TLRs (Hemmi et al.,
2000). In unstimulated cells, TLR9 is located in the endo-
plasmic reticulum (ER). Upon stimulation by CpG DNA,
TLR9 translocates to the membrane of endosomes, where
they recognize their ligands and initiate cellular activation
(Latz et al., 2004). Recently, mounting evidence reveals that
mtDNA provokes the immune response directly via the
activation of TLR9 as its ligand (Wei et al., 2015; Zhang
et al., 2010). The study in our laboratory (Wei et al., 2015)
has shown that cell necrosis induced by cationic nanocarri-
ers and the resulting leakage of mtDNA could trigger severe
inﬂammation in vivo, which is mediated by a pathway
involving TLR9 signaling. The injection of mtDNA can
activate neutrophils and increase the release of matrix
metalloproteinase-8 (MMP-8), a pro-inﬂammatory cytokine,
leading to severe inﬂammation in mouse lungs. Moreover,
the activation of neutrophils by mtDNA through TLR9 path-
way was conﬁrmed by using TLR9−/− mice and TLR9
antagonist ODN2088, and the inﬂammation was reduced in
both TLR9−/−and ODN2088-treated mice (Wei et al., 2015).
In addition to MMP8, interaction of TLR9 with mtDNA could
activate the nuclear factor kappa B (NFκB) signaling and
increase the expression of other pro-inﬂammatory cytokines,
such as tumor necrosis factor-α (TNF-α), interleukin (IL)-6,
IL-1β (Julian et al., 2013; Yu and Bennett, 2014; Zhang et al.,
2014).
Mitochondrial DNA and NLRP3 activation
The Nod-like receptor (NLR) family, pyrin domain containing
3 (NLRP3) inﬂammasome is the most extensively investi-
gated one among the identiﬁed inﬂammasomes, which is
mainly due to its ability to be activated by a wide variety of
ligands (Gurung et al., 2015). Diverse stimuli, including
mitochondrial damage, have been shown to provoke the
NLRP3 inﬂammasome during infection and metabolic dis-
eases (Horng, 2014). Bacterial and viral RNA can also
activate the NLRP3 inﬂammasome (Kanneganti et al., 2006).
Recent studies have shown that mtDNA released in the
cytoplasm plays a key role in provoking the NLRP3 inﬂam-
masome (Nakahira et al., 2011; Shimada et al., 2012).
Nakahira et al. showed that ATP-mediated mtDNA release
depends on the NLRP3 inﬂammasome and mitochondrial
reactive oxygen species (mROS); thus mtDNA ampliﬁes
inﬂammasome activation after the initial trigger (proposed to
be mROS production). By contrast, Shimada et al. further
suggested that the oxidized mtDNA directly bound to NLRP3
and activated the inﬂammasome, suggesting that it initiated
activation of this pathway. Depleting mitochondria of mtDNA
(by ethidium bromide treatment) impaired inﬂammasome
activation and further supported the direct role of mtDNA in
inﬂammasome activation (Nakahira et al., 2011). Interest-
ingly, NLRP3 is required for the translocation of mtDNA into
the cytosol during inﬂammasome activation (Nakahira et al.,
2011). This demonstrates that cytosolic mtDNA can be
identiﬁed as a putative ligand of the NLRP3 inﬂammasome
and mtDNA might act in a positive feedback loop to poten-
tiate the NLRP3 inﬂammasome activation (Gurung et al.,
2015; Horng, 2014).
The NLRP3 inﬂammasome is a cytosolic complex, in
which interaction with the adaptor protein Asc and procas-
pase-1 enables the recruitment and activation of caspase-1,
leading to the maturation of IL-1β and IL-18 and the induction
of pro-inﬂammatory cell death of sentinel cells in the innate
immune system (Horng, 2014; Mariathasan et al., 2006;
Martinon et al., 2006). Mitochondrial DNA also plays a key
role in the activation of the NLRP3 inﬂammasome and
mediates the secretion of IL-1β and IL-18 (Yu and Bennett,
2014).
Mitochondrial DNA and the STING pathway
In addition to interacting with the TLR9 pathway and the
NLRP3 inﬂammasome, mtDNA can also activate the STING
pathway. A recent study (West et al., 2015) has showed that
mitochondrial transcription factor A (TFAM) depletion,
induced genetically or during herpesvirus infection, triggers
disruption of mtDNA stability, which is characterized by
nucleoid loss and enlargement. This results in the release of
fragmented mtDNA that recruits and activates peri-mito-
chondrial cyclic GMP-AMP synthase (cGAS) to generate the
second messenger cyclic GMP-AMP dinucleotide (cGAMP)
and activate endoplasmic-reticulum-resident STING. STING
then activates TANK-binding kinase 1 (TBK1), which phos-
phorylates interferon regulatory factor 3 (IRF3) and results in
IRF3-dependent expression of type I interferon (IFN I) and
other interferon-stimulated genes and augments viral resis-
tance (summarized in Fig. 1). Both responses are found in
innate antiviral defenses to dampen viral propagation. In
summary, herpesvirus infection induces mtDNA stress,
which leads to the activation of antiviral innate immune
responses through the cGAS-STING pathway. Another two
recent studies (Rongvaux et al., 2014; White et al., 2014)
demonstrate that Bak- and Bax- mediated mitochondrial
damage in the absence of activating the downstream
apoptotic caspases induces the release of mtDNA, thereby
triggering cGAS-cGAMP-STING signaling.
To conclude, mtDNA participates in a variety of innate
immune pathways, including mtDNA-TLR9-NFκB axis,
mtDNA-NLRP3-caspase1 pathway and mtDNA-STING-IRF3
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signaling (summarized in Fig. 1), leading to diverse innate
immune responses subsequently mentioned.
MITOCHONDRIAL DNA AND INNATE IMMUNITY
Mitochondrial DNA and antiviral responses
Although known as cellular powerhouses, mitochondria also
regulate programmed cell death pathways and function as
centrally positioned hubs in the innate immune system.
Recently, mitochondria were shown to help elicit cellular
inﬂammation, particularly by inducing antiviral signaling
pathways (West et al., 2011). The cytosolic sensors Retinoic
acid- inducible gene I (RIG-I) and melanoma differentiation-
associated gene 5 (MDA5) recognize distinct viral RNA
species and activate signaling through mitochondrial
antiviral signaling (MAVS), which results in the expression of
cytokines including type I and III interferon to restrict viral
replication (Yoneyama et al., 2015). In addition to mito-
chondria, mtDNA can also contribute to antiviral immunity via
the mtDNA-STING-IRF3-IFN I signaling as mentioned
above. Mitochondrial DNA can be identiﬁed as a cell-intrinsic
trigger of antiviral signaling and cellular monitoring of mtDNA
homeostasis cooperates with canonical virus sensing
mechanisms to fully provoke antiviral innate immunity (West
et al., 2015).
Mitochondrial DNA and antibacterial immunity
It has been reported that mitochondria has the ability to































Figure 1. Mechanisms by which mitochondrial DNA activates innate immunity. Mitochondrial DNA (mtDNA) released from
mitochondria following cell damage and stress (e.g. cationic carriers) can activate TLR9 in endosomes, leading to the transcription of
pro-inﬂammatory cytokine genes and increased release of pro-inﬂammatory cytokines, including MMP-8, TNF-α, IL-6 and IL-1β. In
addition, mtDNA escaped into the cytosol after herpes virus infection, can be detected by the cGAS-cGAMP-STING pathway, which
results in TBK1-IRF3-dependent expression of type I interferon (IFN I) and dampening viral replication. However, the activation of
caspases involved in the intrinsic pathway of apoptosis (caspase-3, caspase-7 and caspase-9) can prevent the activation of IFN
response. Moreover, stimulation such as ATP induces mitochondrial dysfunction resulting in mtDNA release into the cytoplasm,
where it binds to and activates the NLRP3 inﬂammasome. Interaction with the adaptor protein Asc and procaspase-1, the NLRP3
inﬂammasome enables the recruitment and activation of caspase-1, which cleaves pro-IL-1β and pro-IL-18 into their bioactive mature
forms. On the other hand, microtubule-associated protein 1 light chain 3B (LC3B)/Beclin 1-mediated autophagy are involved in the
clearance of mtDNA, and thus negatively regulating the NLRP3 inﬂammasome activation.
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derived from mitochondria plays a key role in macrophage-
associated antibacterial immune responses (West et al.,
2011). Such as mROS, mtDNA also participates in antibac-
terial responses. Certain host immune cells (e.g. neutrophils
and mast cells) use nuclear DNA-based extracellular traps
(ET) (consisting of nuclear DNA, histones and antimicrobial
peptides, etc.) to catch microbial pathogens and kill them
(von Kockritz-Blickwede and Nizet, 2009). It has been shown
that eosinophil can eject mtDNA speciﬁcally, which functions
as an ET to assist in immobilization of the microbial patho-
gens, and thus, the eosinophil can recognize and kill the
microorganism (Youseﬁ et al., 2008). Like neutrophil ET and
mast cell ET, the eosinophil ET process is dependent on
ROS production, but importantly, does not result in cell death
since the eosinophils remain viable after ejection of its
mtDNA. Recently, Morshed and colleagues (Morshed et al.,
2014) observed that both human and mouse basophils are
able to produce mROS and form extracellular mtDNA traps
upon IL-3 priming in the NADPH oxidase-independent form.
Another recent article (Youseﬁ et al., 2015) provides evi-
dence that, in spite of an apparent lack of phagocytic activity,
basophils can kill bacteria through basophils extracellular
traps (BETs) formation, which contains mtDNA and granule
proteins. As mentioned above, the pathogen-induced
mtDNA-based ETs in eosinophils and basophils have
important roles in antibacterial immunity.
In summary, a pathogen-induced mitochondrial stress,
leading to the release of mtDNA, is an evolutionarily bene-
ﬁcial mechanism in the host that ampliﬁes antibacterial and
antiviral signaling in response to pathogen invasion. How-
ever, the aberrant accumulation of damaged mitochondria
and the leakage of mtDNA into the cytosol may also cause
inﬂammatory diseases (Kanneganti et al., 2015).
Mitochondrial DNA and inﬂammatory diseases
It is reported that mtDNA can be detected in the synovial
ﬂuids of rheumatoid arthritis (RA) patients but not in healthy
individuals (Collins et al., 2004), which is also increased in
the plasma of patients with femur fracture (Zhang et al.,
2010) or with acute human immunodeﬁciency virus (HIV)
infection (Cossarizza et al., 2011). Mitochondrial DNA can
activate polymorphonuclear neutrophils through CpG/TLR9
interactions in sterile systemic inﬂammatory response syn-
drome (SIRS) associated with acute trauma (Zhang et al.,
2010). The study in our laboratory (Wei et al., 2015) has
shown that mtDNA released from necrotic cells induced by
cationic carriers can mediate the inﬂammatory responses via
TLR9 signaling, which reveals a novel mechanism about the
inﬂammatory toxicity of cationic carriers and provides a new
vision of designing better and safer cationic carriers for drug
delivery. Moreover, pressure-overload released mtDNA that
escapes autophagy causes inﬂammatory responses in car-
diomyocytes, and is capable of inducing myocarditis and
dilated cardiomyopathy (Oka et al., 2012). Mounting evi-
dence reveals that mtDNA is thought to play a key role
during sterile inﬂammation in the heart (Nakayama and Otsu,
2013). Despite RA, SIRS and heart diseases, mtDNA also
participates in systemic inﬂammation during acute liver fail-
ure (Marques et al., 2012), Parkinson’s disease (Celardo
et al., 2014) and atherosclerosis (Ding et al., 2013) via TLR9-
mediated inﬂammatory responses. To conclude, these data
indicate that mtDNA has a vital role in DAMP-associated
inﬂammation in different pathological disorders.
It has been demonstrated that the NLRP3 pathway par-
ticipates in a variety of important responses such as host
defense, where its activity is beneﬁcial, and the NLRP3
pathway also contributes to metabolic diseases, where it
may play a pathophysiological role (Franchi et al., 2009;
Lamkanﬁ and Dixit, 2012; Strowig et al., 2012; Wen et al.,
2013). Similarly, mtDNA also plays a key role in the activa-
tion of the NLRP3 inﬂammasome and mediates the secretion
of IL-1β and IL-18, which might be associated with the
induction of inﬂammatory disease. It is reported that mtDNA
damage may lead to mitochondrial dysfunction and increase
the secretion of IL-1β, which directly promotes atheroscle-
rosis (Yu and Bennett, 2014). What’s more, the interactions
between mROS/mtDNA and the NLRP3 inﬂammasome
have the ability to facilitate IL-1β release and pancreatic β-
cell death and contribute to type-2 diabetes mellitus pro-
gression (Escames et al., 2012; Nishikawa and Araki, 2007).
CONCLUSIONS AND PERSPECTIVES
Mitochondrial DNA, activation of TLR9, NLRP3 and STING,
is recently discovered and investigated as a key modulator in
innate immune signaling (summarized in Fig. 1). Mitochon-
drial DNA, but not nuclear genomic DNA, generally released
in the cytoplasm after cellular damage and stress, plays an
important role in the development of different kinds of
inﬂammatory diseases, including RA, sterile SIRS, acute
liver failure, atherosclerosis, heart diseases and Parkinson’s
disease, as well as in antibacterial immunity and antiviral
signaling (Collins et al., 2004; Zhang et al., 2010; Marques
et al., 2012; Yu and Bennett, 2014; Oka et al., 2012; Celardo
et al., 2014; Youseﬁ et al., 2015; West et al., 2015). Two
recent articles (Rongvaux et al., 2014; White et al., 2014)
have highlighted the role of mtDNA sensing by the cGAS-
STING pathway. They concurrently published that the acti-
vation of caspases involved in the intrinsic pathway of
apoptosis (caspase-3, caspase-7 and caspase-9) can pre-
vent the activation of IFN response mediated by the release
of mtDNA in cells undergoing apoptosis caused by Bax and
Bak. In addition, microtubule-associated protein 1 light chain
3B (LC3B)/Beclin 1-mediated autophagy are involved in the
clearance of damaged mitochondria, and thus negatively
regulate the NLRP3 inﬂammasome activation (Nakahira
et al., 2011). Two recent studies reported that the γ-
aminobutyric acid A receptor-associated protein (Gabarap)
and α7 nicotinic acetylcholine receptor (α7 nAchR), respec-
tively, are involved in mitochondrial quality control in mac-
rophages, and their deﬁciency enhance the mtDNA/NLRP3
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dependent inﬂammatory responses (Lu et al., 2014; Zhang
et al., 2013). The discovery of the molecular pathways that
mtDNA activates while it is recognized by innate immune
cells might provide us with new targets for treatment of the
related diseases.
However, several questions remain. First, are there more
mtDNA pathways in innate immunity that are not discov-
ered? Second, in addition to above-mentioned diseases,
what are the other diseases, such as cancer, related with
mtDNA? Last but not least, what mechanisms exist in the
process of mtDNA being released from the mitochondria?
One study suggests that mtDNA release is mediated by
mitochondrial permeability transition (MPT) based on sen-
sitivity to cyclosporine A, which is plausible if MPT is followed
by osmotic swelling and mitochondrial rupture (Nakahira
et al., 2011). A recent study demonstrates that the hydrolysis
of the mitochondrial membrane by secreted phospholipase
A2 IIA (sPLA2-IIA) yields inﬂammatory mediators (e.g.
lysophospholipids and mtDNA) that promote leukocyte acti-
vation, leading to inﬂammatory responses (Boudreau et al.,
2014). It is important to explore more mechanisms between
mtDNA and the innate immune responses.
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